Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. Its drug delivery and antisense technology is the ...
Path to Independence (P2I) is an inclusive, two-year, non-degree certificate program offering a college experience to students with intellectual and developmental disabilities. Founded in 2013 by Mary ...